The STAR Study: a real-world, international, observational study of the safety and tolerability of, and adherence to, serum-free subcutaneous interferon β-1a in patients with relapsing multiple sclerosis.
about
Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review.Reasons for discontinuation of subcutaneous interferon β-1a three times a week among patients with multiple sclerosis: a real-world cohort studyHow many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis.The importance of collecting structured clinical information on multiple sclerosis.Multiple sclerosis patients treated with intramuscular IFN-β-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction.
P2860
The STAR Study: a real-world, international, observational study of the safety and tolerability of, and adherence to, serum-free subcutaneous interferon β-1a in patients with relapsing multiple sclerosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The STAR Study: a real-world, ...... relapsing multiple sclerosis.
@en
type
label
The STAR Study: a real-world, ...... relapsing multiple sclerosis.
@en
prefLabel
The STAR Study: a real-world, ...... relapsing multiple sclerosis.
@en
P2093
P1476
The STAR Study: a real-world, ...... h relapsing multiple sclerosis
@en
P2093
Hanna Kuusisto
Kurt Marhardt
Lizette Ghazi-Visser
Michalis Arvanitis
Nikolaos Vlaikidis
Raymond Hupperts
STAR Study Group
P304
P356
10.1016/J.CLINTHERA.2014.04.002
P577
2014-05-05T00:00:00Z